Innocan Pharma (INNPF) Gross Margin (2024 - 2025)
Innocan Pharma (INNPF) recorded Gross Margin of 88.81% in the quarter ended Dec 31, 2025, up 7.18 percentage points from 81.63% a year earlier but down 1.94 percentage points from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) Gross Margin (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innocan Pharma reported Gross Margin of 89.93%, up 0.97 percentage points from the prior year.
- Across earlier years, Gross Margin came in at 88.96% in the year ended Dec 31, 2024 (+1.25 pp) and 87.71% in the year ended Dec 31, 2023.
- Quarterly Gross Margin has ranged from 81.63% in the quarter ended Dec 31, 2024 to 92.53% in the quarter ended Jun 30, 2024 over the past five years.
- On a year-over-year basis, Gross Margin rose in three of the last four quarters, with an average year-over-year change of +1.56 percentage points.
- Per Business Quant, the preceding three quarters came in at 90.75% (quarter ended Sep 30, 2025), 88.42% (quarter ended Jun 30, 2025) and 91.26% (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 75.71% |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 88.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 88.81% |
| Sep 30, 2025 | 90.75% |
| Jun 30, 2025 | 88.42% |
| Mar 31, 2025 | 91.26% |
| Dec 31, 2024 | 81.63% |
| Sep 30, 2024 | 90.20% |
| Jun 30, 2024 | 92.53% |
| Mar 31, 2024 | 88.67% |
API Access
Innocan Pharma Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();